This finding not only broadens our understanding of the non-glycolytic mechanisms of PFKP in tumorigenesis but also explains why the MAPK/ERK signaling pathway is highly activated in HNSCC. The gene discussed is MAPK1; the disease is head and neck squamous cell carcinoma.